NCT05868057View on ClinicalTrials.gov

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

June 9, 2023

Study Completion Date

October 20, 2023

Conditions
Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
Interventions
DRUG

SHR7280 tablets

SHR7280 tablets 1 time

DRUG

SHR7280 dry suspension

SHR7280 dry suspension 1 time

Trial Locations (1)

511447

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05868057 - A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets | Biotech Hunter | Biotech Hunter